SCA
GMAB icon

Snowden Capital Advisors’s Genmab GMAB Stock Holding History

Snowden Capital Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
10,011
-325
-3% -$8.64K 0.01% 1115
2026
Q1 		$277K Buy
10,336
+2,275
+28% +$68.2K 0.01% 1066
2025
Q4 		$248K Buy
8,061
+1,290
+19% +$40.2K 0.01% 1123
2025
Q3 		$208K Buy
+6,771
New +$165K 0.01% 1181
2024
Q2 		– Sell
-6,861
Closed -$205K – 1203
2024
Q1 		$205K Buy
+6,861
New +$202K 0.01% 1123
2023
Q4 		– Sell
-5,721
Closed -$202K – 1122
2023
Q3 		$202K Buy
5,721
+155
+3% +$5.91K 0.01% 1019
2023
Q2 		$212K Buy
5,566
+158
+3% +$6.3K 0.01% 1085
2023
Q1 		$204K Buy
5,408
+633
+13% +$24.3K 0.01% 1076
2022
Q4 		$202K Buy
+4,775
New +$197K 0.01% 1070
2022
Q1 		– Sell
-423
Closed -$16K – 1452
2021
Q4 		$16K Buy
+423
New +$17.6K ﹤0.01% 1395

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Snowden Capital Advisors's GMAB Position: Q2 2026 in Review

Snowden Capital Advisors reduced its Genmab (GMAB) stake by 3.1% in Q2 2026, selling an estimated $8.64K and leaving 10,011 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #1115.

Snowden Capital Advisors first reported a position in GMAB in Q4 2021 and has held it in 10 quarters since. The position peaked at $277K in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Snowden Capital Advisors held 10,011 shares of Genmab worth $275K as of Q2 2026.
  • Snowden Capital Advisors sold 325 Genmab shares in Q2 2026, an estimated $8.64K.
  • Genmab made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1115 holding.
  • Snowden Capital Advisors first reported a position in Genmab in Q4 2021 and has held it in 10 quarters since.
  • Snowden Capital Advisors's Genmab position peaked at $277K in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.